Kir3-Based Inward Rectifier Potassium Current: Potential Role in Atrial Tachycardia Remodeling Effects on Atrial Repolarization and Arrhythmias

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-04-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.105.561738PMID 16585394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation

  2005cited by this paper
• Atrial Tachycardia Remodeling of Pulmonary Vein Cardiomyocytes: Comparison With Left Atrium and Potential Relation to Arrhythmogenesis

  2005cited by this paper
• Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation.

  2005cited by this paper
• Constitutively Active G-Protein-Gated Inwardly Rectifying K+ Channels in Dendrites of Hippocampal CA1 Pyramidal Neurons

  2005cited by this paper
• “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat

  2004cited by this paper
• Characterization of a hyperpolarization‐activated time‐dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium

  2004influential reference
• Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels

  2004cited by this paper
• Epicardial Mapping of Chronic Atrial Fibrillation in Patients: Preliminary Observations

  2004cited by this paper
• Defining “Culprit Mechanisms” in Arrhythmogenic Cardiac Remodeling

  2004cited by this paper
• Remodeling of cardiomyocyte ion channels in human atrial fibrillation

  2003cited by this paper
• Overview of the Management of Atrial Fibrillation:

  2003cited by this paper
• Cholinergic atrial fibrillation: I(K,ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics.

  2003cited by this paper
• Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation.

  2002cited by this paper
• Electrical, contractile and structural remodeling during atrial fibrillation.

  2002cited by this paper
• Density and function of inward currents in right atrial cells from chronically fibrillating canine atria.

  2002cited by this paper
• New ideas about atrial fibrillation 50 years on

  2002cited by this paper
• Left-to-Right Gradient of Atrial Frequencies During Acute Atrial Fibrillation in the Isolated Sheep Heart

  2001cited by this paper
• The bee venom peptide tertiapin underlines the role of IKACh in acetylcholine‐induced atrioventricular blocks

  2000cited by this paper
• Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes.

  2000cited by this paper
• Molecular evidence for a role of Shaw (Kv3) potassium channel subunits in potassium currents of dog atrium

  2000cited by this paper
• Ionic mechanisms of electrical remodeling in human atrial fibrillation.

  1999cited by this paper
• Atrial L-type Ca2+ currents and human atrial fibrillation.

  1999cited by this paper
• Synthesis of a stable form of tertiapin: a high-affinity inhibitor for inward-rectifier K+ channels.

  1999cited by this paper
• The Molecular and Ionic Specificity of Antiarrhythmic Drug Actions

  1999cited by this paper
• Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation.

  1997cited by this paper
• Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation.

  1997cited by this paper
• Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation.

  1997cited by this paper
• Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells.

  1996cited by this paper
• Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.

  1995cited by this paper
• Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation.

  1995cited by this paper
• Antiarrhythmic agents act differently on the activation phase of the ACh‐response in guinea‐pig atrial myocytes

  1993cited by this paper
• Membrane-bound nucleoside diphosphate kinase activity in atrial cells of frog, guinea pig, and human.

  1992cited by this paper
• The electrophysiological effects of acetylcholine in single human atrial cells.

  1987cited by this paper

• Role of Structural Versus Cellular Remodeling in Atrial Arrhythmogenesis: Insights From Personalized Digital Twins.

  2025cites this paper
• Metabolic Remodeling and Mitochondrial Stress in Atrial Fibrillation: Mechanisms and Translational Targets

  2025cites this paper
• The Role of KACh Channels in Atrial Fibrillation

  2024cites this paper
• Ion channel dysfunction and fibrosis in atrial fibrillation: Two sides of the same coin

  2024cites this paper
• Oxidative stress and atrial fibrillation.

  2024cites this paper
• Selective Inhibition of Pulmonary Vein Excitability by Constitutively Active GIRK Channels Blockade in Rats

  2023cites this paper
• The role of structural vs cellular remodeling in arrhythmogenesis: personalized computer models of atrial fibrillation

  2023cites this paper
• Increased GIRK channel activity prevents arrhythmia in mice with heart failure by enhancing ventricular repolarization

  2023cites this paper
• The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives

  2023cites this paper
• Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?

  2023cites this paper
• The W101C KCNJ5 Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes

  2023cites this paper
• Autoimmune Atrial Fibrillation

  2023cites this paper
• Inhibition of the voltage-gated potassium channel Kv1.5 by hydrogen sulfide attenuates remodeling through S-nitrosylation-mediated signaling

  2023cites this paper
• The Arf6/PIP5K pathway activates IKACh in cigarette smoke mediated atrial fibrillation.

  2022cites this paper
• The Relevance of GIRK Channels in Heart Function

  2022cites this paper
• Bioengineered peptibodies as blockers of ion channels

  2022cites this paper
• Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment

  2022cites this paper
• IKACh is constitutively active via PKC epsilon in aging mediated atrial fibrillation

  2022cites this paper
• Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

  2021cites this paper
• Characterization of VU0468554, a New Selective Inhibitor of Cardiac G Protein–Gated Inwardly Rectifying K+ Channels

  2021cites this paper
• Cohesin-protein Shugoshin-1 controls cardiac automaticity via HCN4 pacemaker channel

  2021cites this paper
• 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

  2021cites this paper
• Pathophysiology and Therapeutic Relevance of PI3K(p110α) Protein in Atrial Fibrillation - A Non-interventional Molecular Therapy Strategy.

  2021cites this paper
• Pathophysiology of atrial fibrillation. Systemic review Patofizjologia migotania

  2021cites this paper
• Characterization of VU0468554, a New Selective Inhibitor of Cardiac G Protein – Gated Inwardly Rectifying K 1 Channels

  2021cites this paper
• Arrhythmias

  2021cites this paper
• A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels

  2021cites this paper
• Hypercholesterolemia Induces Up-regulation of K ACh Cardiac Currents via a Mechanism Independent of Phosphatidylinositol 4,5-Bisphosphate and G (cid:1)(cid:2) *

  2020cites this paper
• Inward Rectifier K+ Currents Contribute to the Proarrhythmic Electrical Phenotype of Atria Overexpressing Cyclic Adenosine Monophosphate Response Element Modulator Isoform CREM‐IbΔC‐X

  2020cites this paper
• Attenuation of Oxidative Injury with Targeted Expression of NOX2 shRNA Prevents Onset and Maintenance of Electrical Remodeling in the Canine Atrium: A Novel Gene Therapy Approach to Atrial Fibrillation.

  2020cites this paper
• Genetics and Epigenetics of Atrial Fibrillation

  2020cites this paper
• Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy

  2020cites this paper
• GIRK channel activity of Hungarian mushrooms: From screening to biologically active metabolites.

  2019cites this paper
• Disruption of NOX2-dependent Oxidative Injury with a Targeted Gene-Therapy Approach Prevents Atrial Fibrillation in a Canine Model

  2019cites this paper
• Atria-selective antiarrhythmic drugs in need of alliance partners.

  2019cites this paper
• Mechanisms and Drug Development in Atrial Fibrillation

  2018cites this paper
• Atrium‐specific ion channels in the zebrafish—A role of IKACh in atrial repolarization

  2018cites this paper
• Comparison of the effects of IK,ACh, IKr, and INa block in conscious dogs with atrial fibrillation and on action potentials in remodeled atrial trabeculae.

  2018influential citation
• Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging

  2018cites this paper
• 42 – The Molecular Pathophysiology of Atrial Fibrillation

  2018cites this paper
• 13.03 – Cardiac Physiology and Pharmacology

  2018cites this paper
• Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance.

  2017cites this paper
• Testing novel pharmacological strategies for the management of atrial fibrillation in a large animal experimental model

  2017cites this paper
• Atrial-selective K+ channel blockers: potential antiarrhythmic drugs in atrial fibrillation?

  2017cites this paper
• Draft Atrial-selective K + channel blockers – potential antiarrhythmic drugs in atrial fibrillation ? 1

  2017cites this paper
• Taurine Prevents the Electrical Remodeling in Ach-CaCl2 Induced Atrial Fibrillation in Rats.

  2017cites this paper
• Venom-derived peptides inhibiting Kir channels: Past, present, and future.

  2017cites this paper
• Atrial fibrillation: Therapeutic potential of atrial K+ channel blockers.

  2017cites this paper
• Potential Role of Regulator of G‐Protein Signaling 5 in the Protection of Vagal‐Related Bradycardia and Atrial Tachyarrhythmia

  2016cites this paper
• A Mathematical Model of Neonatal Rat Atrial Monolayers with Constitutively Active Acetylcholine-Mediated K+ Current

  2016influential citation
• Constitutively Active Acetylcholine-Dependent Potassium Current Increases Atrial Defi brillation Threshold by Favoring Post-Shock Re-Initiation. Role of I KACh-c in Atrial Defi brillation Threshold

  2016cites this paper
• The molecular and functional identities of atrial cardiomyocytes in health and disease.

  2016cites this paper
• Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits.

  2016cites this paper
• Experimentelle Untersuchungen zur antiarrhythmischen Wirkung von Antazolin am isolierten Kaninchenherzen

  2016influential citation
• Chronotropic Modulation of the Source-Sink Relationship of Sinoatrial-Atrial Impulse Conduction and Its Significance to Initiation of AF: A One-Dimensional Model Study

  2015cites this paper
• Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans.

  2015cites this paper
• Constitutively Active Acetylcholine-Dependent Potassium Current Increases Atrial Defibrillation Threshold by Favoring Post-Shock Re-Initiation

  2015cites this paper
• Atrial structure and function and its implications for current and emerging treatments for atrial fibrillation.

  2015cites this paper
• L’effet de la surexpression du récepteur de type 1 à l’angiotensine II sur les courants potassiques et calciques au niveau des oreillettes

  2015cites this paper
• The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy

  2015cites this paper
• The Roles of Gβγ and Gα in Gating and Regulation of GIRK Channels.

  2015cites this paper
• Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?

  2015cites this paper
• RGS Redundancy and Implications in GPCR-GIRK Signaling.

  2015cites this paper
• Novel K+ Channel Targets in Atrial Fibrillation Drug Development—Where Are We?

  2015cites this paper
• Treatment of Atrial Fibrillation and Atrial Flutter

  2015cites this paper
• [New developments in the antiarrhythmic therapy of atrial fibrillation].

  2014cites this paper
• Attenuation of Acetylcholine Activated Potassium Current (IKACh) by Simvastatin, Not Pravastatin in Mouse Atrial Cardiomyocyte: Possible Atrial Fibrillation Preventing Effects of Statin

  2014cites this paper
• Atrial Fibrillation Therapy Now and in the Future: Drugs, Biologicals, and Ablation

  2014cites this paper
• 38 – Cholinergic and Constitutive Regulation of Atrial Potassium Channel

  2014cites this paper
• Present challenges and future solutions : New directions in cardiac arrhythmia management

  2014cites this paper
• Constitutive activity of the acetylcholine-activated potassium current IK,ACh in cardiomyocytes.

  2014cites this paper
• Mechanisms of Atrial Fibrillation

  2014cites this paper
• 45 – The Molecular Pathophysiology of Atrial Fibrillation

  2014cites this paper
• Differential effects of genetically-encoded Gβγ scavengers on receptor-activated and basal Kir3.1/Kir3.4 channel current in rat atrial myocytes.

  2014cites this paper
• Mechanisms Underlying the Pathogenesis of Atrial Arrhythmias in RGS4-deficient Mice

  2014cites this paper
• New directions in cardiac arrhythmia management: present challenges and future solutions.

  2014cites this paper
• Neue Entwicklungen in der antiarrhythmischen Therapie des Vorhofflimmerns

  2014cites this paper
• Looking into a Conceptual Framework of ROS–miRNA–Atrial Fibrillation

  2014cites this paper
• Effects of the Selective KACh Channel Blocker NTC-801 on Atrial Fibrillation in a Canine Model of Atrial Tachypacing: Comparison With Class Ic and III Drugs

  2014cites this paper
• Future perspectives in the pharmacological treatment of atrial fibrillation and ventricular arrhythmias in heart failure.

  2014cites this paper
• Atrial remodeling and atrial fibrillation: recent advances and translational perspectives.

  2014cites this paper
• The Role of MicroRNA Regulation of Cardiac Ion Channel in Arrhythmia

  2013influential citation
• Atrial selectivity of antiarrhythmic drugs

  2013cites this paper
• [Cardiac potassium channels: molecular structure, physiology, pathophysiology and therapeutic implications].

  2013cites this paper
• Atrial remodeling: new pathophysiological mechanism of atrial fibrillation.

  2013cites this paper
• The G-protein–gated K+ channel, IKACh, is required for regulation of pacemaker activity and recovery of resting heart rate after sympathetic stimulation

  2013cites this paper
• Atrial fibrillation

  2013cites this paper
• The prevalence and clinical correlates of atrial fibrillation in those aged 70 and over in the Hai district of northern Tanzania

  2013influential citation
• Mechanisms of Action of Antiarrhythmic Drugs in Atrial Fibrillation

  2013cites this paper
• Tissue-specific effects of acetylcholine in the canine heart.

  2013influential citation
• Heterogeneous atrial wall thickness and stretch promote scroll waves anchoring during atrial fibrillation.

  2012influential citation
• Acetylcholine-Activated Potassium Channel as a Novel Target for AF Treatment

  2012cites this paper
• Kir3 channel signalling complexes in cardiac arrhythmias

  2012cites this paper
• Chapter 2 Phosphoinositides and Cardiovascular Diseases

  2012cites this paper
• Novel Approaches for Pharmacological Management of Atrial Fibrillation

  2012cites this paper
• Principios básicos de las nuevas estrategias farmacológicas antiarrítmicas en fibrilación auricular

  2012cites this paper
• Thiéno- et furo- pyrimidines et pyridines, convenant comme inhibiteurs du canal potassium

  2012cites this paper
• Ion channel drug discovery: challenges and future directions.

  2012cites this paper
• Cardiac ion channels and mechanisms for protection against atrial fibrillation.

  2012cites this paper
• Voltage-dependent open-channel block of G protein-gated inward-rectifying K+ (GIRK) current in rat atrial myocytes by tamoxifen

  2012cites this paper